Letrozole Tablet Ip

Letrozole belongs to a class of medications known as aromatase inhibitors, which work by blocking the enzyme aromatase, responsible for converting other hormones into estrogen in the body. Since many breast cancers rely on estrogen to grow, reducing its production helps slow or stop the progression of hormone receptor-positive breast cancer. It is commonly used in postmenopausal women with early-stage or advanced breast cancer, either as an initial treatment or following other hormone therapies, depending on the individual treatment plan. Letrozole is also sometimes used off-label to support ovulation in certain fertility treatments, given its hormone-modulating effects, though its primary and most established use remains in breast cancer care. The tablets are taken orally, usually once daily, offering a convenient and consistent dosing schedule for long-term hormone therapy. Regular monitoring, including imaging studies and bone density checks, is an important part of treatment to help track the body's response and support overall health during therapy. Many patients experience meaningful disease control and improved outcomes as part of a comprehensive treatment plan involving Letrozole. Ongoing follow-up with an oncologist helps ensure the treatment remains appropriate and effective over time. As with all hormone therapies for cancer treatment, Letrozole tablets should be used under the close supervision of a healthcare provider experienced in breast cancer care.